Lysophosphatidylserine Stimulates Chemotactic Migration of Colorectal Cancer Cells Through GPR34 and PI3K/Akt Pathway

被引:1
|
作者
Iida, Yuuki [1 ]
Tsuno, Nelson H. [2 ]
Kishikawa, Junko [1 ]
Kaneko, Kensuke [1 ]
Murono, Koji [1 ]
Kawai, Kazushige [1 ]
Ikeda, Toshiyuki [2 ]
Ishihara, Soichiro [1 ]
Yamaguchi, Hironori [1 ]
Sunami, Eiji [1 ]
Kitayama, Joji [1 ]
Yatomi, Yutaka [3 ]
Watanabe, Toshiaki [1 ]
机构
[1] Univ Tokyo, Fac Med Sci, Dept Surg Oncol, Tokyo 1138655, Japan
[2] Univ Tokyo, Fac Med Sci, Dept Transfus Med, Tokyo 1138655, Japan
[3] Univ Tokyo, Fac Med Sci, Dept Clin Lab Med, Tokyo 1138655, Japan
关键词
Lysophosphatidylserine; GPR34; colorectal cancer; chemotactic migration; BINDS ANIONIC PHOSPHOLIPIDS; TUMOR BLOOD-VESSELS; MONOCLONAL-ANTIBODY; AUTOTAXIN; ROLES; MICE;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background: Lysophosphatidylserine (lysoPS) is a type of lysophospholipid mediator, which is involved in allergic conditions and tumor progression. We investigated the physiological function of lysoPS on colorectal cancer (CRC) cell lines, as well as the involved receptor and signaling pathways. Materials and Methods: Expression of lysoPS receptors on six cell lines was examined by reverse transcription-polymerase chain reaction (RT-PCR). The physiological functions of lysoPS were investigated, and experiments using small interfering RNA (siRNA) or inhibitors of the signaling pathways were conducted. Results: Among the three lysoPS receptors, GPR34 was highly expressed on all cell lines. LysoPS stimulated the chemotactic migratory ability. Wortmannin inhibited the migratory ability, as well as the GPR34 knock-down, strongly suggestive of the involvement of this receptor in the PI3K/Akt pathway. Conclusion: The involved receptor and pathways in the migratory ability in response to lysoPS was demonstrated, which opens premises for targeting as a new strategy for prevention and treatment of colorectal cancer.
引用
收藏
页码:5465 / 5472
页数:8
相关论文
共 50 条
  • [21] EFFECTS OF SULFORAPHANE ON APOPTOSIS AND PI3K/AKT/MTOR PHOSPHORYLATION PATHWAY IN COLORECTAL CANCER CELLS
    Jiang, Yuanxue
    Kuang, Meiling
    Deng, Caijiu
    ACTA MEDICA MEDITERRANEA, 2022, 38 (01): : 227 - 231
  • [22] PI3K/Akt signalling pathway and cancer
    Vara, JAF
    Casado, E
    de Castro, J
    Cejas, P
    Belda-Iniesta, C
    González-Barón, M
    CANCER TREATMENT REVIEWS, 2004, 30 (02) : 193 - 204
  • [23] Salidroside induces apoptosis and autophagy in human colorectal cancer cells through inhibition of PI3K/Akt/mTOR pathway
    Fan, Xiang-Jun
    Wang, Yao
    Wang, Lei
    Zhu, Mingyan
    ONCOLOGY REPORTS, 2016, 36 (06) : 3559 - 3567
  • [24] Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway
    Wang, Rong
    Li, Rizhao
    Yang, Huibing
    Chen, Xuejiao
    Wu, Liangliang
    Zheng, Xiaohui
    Jin, Yuepeng
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2024, 150 (03)
  • [25] Isoliquiritigenin Inhibits the Growth of Colorectal Cancer Cells through the ESR2/PI3K/AKT Signalling Pathway
    Luo, Fenglin
    Tang, Yimeng
    Zheng, Lin
    Yang, Ying
    Gao, Haoyue
    Tian, Shiya
    Chen, Hongyu
    Tang, Chenxi
    Tang, Shanshan
    Man, Qiong
    Wu, Yiying
    PHARMACEUTICALS, 2024, 17 (01)
  • [26] Flavokawain C inhibits proliferation and migration of liver cancer cells through FAK/PI3K/AKT signaling pathway
    Rong Wang
    Rizhao Li
    Huibing Yang
    Xuejiao Chen
    Liangliang Wu
    Xiaohui Zheng
    Yuepeng Jin
    Journal of Cancer Research and Clinical Oncology, 150
  • [27] NCOA5 promotes proliferation, migration and invasion of colorectal cancer cells via activation of PI3K/AKT pathway
    Sun, Kailv
    Wang, Sheng
    He, Jun
    Xie, Yufeng
    He, Yang
    Wang, Zhenxin
    Qin, Lei
    ONCOTARGET, 2017, 8 (64) : 107932 - 107946
  • [28] PI3K/Akt/mTOR Signaling Pathway as a Target for Colorectal Cancer Treatment
    Leiphrakpam, Premila D.
    Are, Chandrakanth
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (06)
  • [29] Cholesterol Promotes Colorectal Cancer Growth by Activating the PI3K/AKT Pathway
    Wu, Cheng
    Wang, Ming
    Shi, Hui
    JOURNAL OF ONCOLOGY, 2022, 2022
  • [30] APLN promotes the proliferation, migration, and glycolysis of cervical cancer through the PI3K/AKT/mTOR pathway
    Wang, Qi
    Wang, Bingyu
    Zhang, Wenjing
    Zhang, Teng
    Liu, Qingqing
    Jiao, Xinlin
    Ye, Jinwen
    Hao, Yiping
    Gao, Qun
    Ma, Guangzhen
    Hao, Chunyan
    Cui, Baoxia
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 2024, 755